Kaisha Lifesciences Private Limited, a active private limited company, was established on 06 July 2010 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74120MH2010PTC205291. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.80 Cr.
Formerly known as Sovereignty Pharma Private Limited. It upholds a compliant status. Employing 40 professional, Its leadership includes Kairus Shavak Dadachanji (Director), Sangeeta Hanurmesh Rivankar (Whole-Time Director), Rishad Kairus Dadachanji (Managing Director). Past directors included Jimmy Jehangir Parakh, Kairus Shavak Dadachanji, Shapoorji Pallonji Mistry. It holds ₹16.51 Cr open charges and ₹1.50 M settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 72-73, 7Th Floor, Plot 215, Free Press House Free Press Journal Marg, Nariman Point, Mumbai, Maharashtra, 400021.
U74120MH2010PTC205291
205291
06 July 2010
₹10.00 Cr
₹9.80 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kaisha Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kairus Shavak Dadachanji | Director | 22 Sep 2022 | Current |
| Sangeeta Hanurmesh Rivankar | Whole-Time Director | 01 Jun 2024 | Current |
| Rishad Kairus Dadachanji | Managing Director | 28 May 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 01 Oct 2022 | Past |
| Pramod Abcsdd | Director | 01 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kaisha Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.51% decrease. The company also saw a substantial improvement in profitability, with a 480.94% increase in profit. The company's net worth Soared by an impressive increase of 639.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kaisha Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹165,050,000.00
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2025 | Others | ₹2.50 M | Open |
| 24 Oct 2024 | Others | ₹1.05 M | Open |
| 03 Nov 2022 | Others | ₹1.50 M | Open |
| 02 Dec 2021 | Others | ₹8.00 Cr | Open |
| 30 Nov 2021 | Others | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Kaisha Lifesciences has a workforce of 40 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kaisha Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaisha Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kaisha Lifesciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
Progress on A charge registered on 03 Nov 2022 via Charge ID 100647834 with Others was fully satisfied on 15 Apr 2025. was documented.
Kaisha Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.25 Cr with Charge ID 101039915 was registered on 24 Jan 2025. was documented.
Progress on A charge with Others amounted to Rs. 0.11 Cr with Charge ID 100995673 was registered on 24 Oct 2024. was documented.
Progress on Sangeeta Hanurmesh Rivankar was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jun 2024 & has been associated with this company since 1 year 6 months . was documented.
The CIN of Kaisha Lifesciences Private Limited is U74120MH2010PTC205291.
Kaisha Lifesciences Private Limited is headquartered at 72-73, 7Th Floor, Plot 215, Free Press House Free Press Journal Marg, Nariman Point, Mumbai, Maharashtra, 400021.
Kaisha Lifesciences Private Limited was incorporated on 06 July 2010.
The current directors of Kaisha Lifesciences Private Limited are
The primary industry of Kaisha Lifesciences Private Limited is Manufacturing.
Kaisha Lifesciences Private Limited is unlisted.
The authorized capital of Kaisha Lifesciences Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.80 Cr.
The compliance status of Kaisha Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX